APA (7th ed.) Citation

L, B., D, O., L, V. d. B., E, V. C., SE, B., J, V. d. B., & J, B. (2025). CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma. Cancers, 17(24), . https://doi.org/10.3390/cancers17243902

Chicago Style (17th ed.) Citation

L, Brancato, Osok D, Van den Bossche L, Van Cutsem E, Bates SE, Van den Bossche J, and Bogers J. "CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma." Cancers 17, no. 24 (2025). https://doi.org/10.3390/cancers17243902.

MLA (9th ed.) Citation

L, Brancato, et al. "CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma." Cancers, vol. 17, no. 24, 2025, https://doi.org/10.3390/cancers17243902.